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Lymphocyte and Brain Neurotoxic Esterase: Dose and Time Dependence of Inhibition in the 
Hen Examined with Three Organophosphorus Esters. SCHWAB, B. W. AND RICHARDSON, R. J. 
( 1986). Toxicol. Appl. Pharmacol. 83,1-9. Certain organic phosphorus esters produce sensorimotor 
axonopathy in man and other species. There is an excellent correlation between the capacity of 
an organophosphorus compound to produce axonopathy and its ability to inhibit brain neurotoxic 
esterase (NTE) in hens. Because NTE is present in peripheral lymphocytes of both hen and man, 
it has been suggested that the lymphocyte enzyme might be useful both in experimental and 
clinical situations as an indicator of exposure to organophosphorus compounds producing ax- 
onopathy. Diethyl 4-nitrophenyl phosphate (paraoxon), tri-Zcresyl phosphate (TOCP), methyl 
2,5dichloro+bromophenyl phenylphosphonothionate (leptophos), and di-n-butyl-2,2-dichlo- 
rovinyl phosphate (di-n-butyl dichlorvos, DBDCV) were used to examine the relationship between 
lymphocyte and brain NTE inhibition in hens. As expected, paraoxon (0.75 mgjkg) did not 
inhibit NTE in brain or lymphocytes. TOCP (10 to 100 mgjkg), leptophos (25 to 150 mg/kg), 
and DBDCV (1 .O to 4.0 mg/kg) inhibited both brain and lymphocyte NTE activity in a dose- 
related manner with good correlation of inhibition between tissues taken 24 hr after exposure 
(r2 = 0.53 to 0.67; p < 0.020 to 0.001). However, correlation of inhibition between tissues taken 
from animals killed 48 hr after exposures was poor (r’ = 0.15 to 0.30; p < 0.10 to 0.05), with 
consistently less inhibition of lymphocyte NTE relative to brain NTE. This study indicates that 
assay of lymphocyte NTE can provide a good monitor of exposure to axonotoxic organophosphorus 
compounds within 24 hr between exposure and measurement. o 1986 Academic mess, IW. 
Exposure to certain organic phosphorus esters 
produces sensorimotor neuropathy in hu- 
mans. Adult laying hens (Gallus gallus do- 
mesticus) are used to provide a model of this 
condition for laboratory studies. Organophos- 
phorus neuropathy is characterized morpho- 
logically as axonal degeneration, and both 
clinical and pathological alterations are de- 
layed in onset, appearing 8 to 14 days follow- 
ing a single exposure to the toxic compound 
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(Davis and Richardson, 1980; Johnson, 1982). 
Organophosphorus compounds producing 
axonopathy phosphorylate and thereby inhibit 
neurotoxic esterase (NTE), an enzyme first 
identified in hen brain. NTE is resistant to 
compounds such as diethyl 4nitrophenyl 
phosphate (paraoxon) and tetraethyl pyro- 
phosphate (TEPP), potent acetylcholinesterase 
inhibitors which do not produce neurodege- 
neration (Richardson, 1984). There is an ex- 
cellent correlation between the capacity of an 
organophosphorus compound to inhibit hen 
brain NTE by 70 to 90% within 1 to 2 days 
after dosing and the production of clinically 
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evident axonopathy some 2 weeks later (Lotti phate, TOCP, practical grade) were purchased from Sigma 
and Johnson, 1978, 1980) provided that the Chemical Company (St. Louis, MO.), Chem Service, Inc. 
compound is also subject to cleavage of a side (West Chester, Pa.), and Eastman Kodak Company 
chain (aging) after the phosphorylation reac- 
(Rochester, N. Y.), respectively. Di-n-butyl-2,2-dichlo- 
tion has taken place (Johnson, 1974). 
rovinyl phosphate (di-n-butyl dichlorvos, DBDCV, 95% 
pure) was custom synthesized by Ash-Stevens, Inc. (De- 
It was first shown in our laboratory that pe- troit, Mich.). All other reagents for NTE and acetylcho- 
ripheral lymphocytes from the hen possess an linesterase assays were from Sigma Chemical Company, 
esteratic activity which behaves in a manner with the exception of 4-aminoantipyrine (Eastman Kodak 
identical to hen brain NTE with respect to in 
Co., 98% pure), and were used without further purification. 
vitro substrate and inhibitor specificities, pH 
N,N’-di-2-propyl phosphorodiamidofluoridate (mipafox) 
and phenyl valerate (PV) were synthesized and purified 
optima, and heat inactivation rates (Dudek in our laboratory, according to methods described by 
and Richardson, 1980, 1982; Richardson and Johnson (1977). Aqueous solutions were prepared with 
Dudek, 1983). NTE activity also exists in hu- deionized-distilled water. 
man lymphocytes and platelets (Bleeker et al., 
1983; Richardson and Dudek, 1983; Bertoncin 
Treatment Regimen 
et al., 1985). If the time course and dose de- 
pendence of NTE inhibition in lymphocytes 
Paraoxon, TOCP, and DBDCV were mixed with corn 
were similar to those in brain, the assay of 
oil and introduced into the crop of hens (at least three per 
group) by steel gavage tube. Leptophos, a crystalline solid, 
lymphocyte NTE could be used to monitor was placed in gelatin capsules for introduction into the 
exposure to axonotoxic organophosphorus crop. All animals were fasted overnight prior to dosing 
compounds. We previously observed good 
and for 4 hr postexposure; tap water was given ad libitum 
correlation between brain and lymphocyte 
throughout. Control animals received an equivalent vol- 
NTE inhibition 4 hr following exposure of 
ume of corn oil vehicle (2.0 ml/kg body wt) or an empty 
gelatin capsule. The dose of paraoxon was 0.75 mg/kg 
hens to a variety of NTE inhibitors (Dudek et body wt. Other compounds were given in a range of doses 
al., 1979; Richardson and Dudek, 1983). This (TOCP: 10, 50, and 100 mg/kg; leptophos: 25, 75, 150 
report further details the relationship between 
mg/kg; and DBDCV: 1.0, 2.0, 3.0, and 4.0 mg/kg). Hens 
lymphocyte and brain NTE inhibition in re- 
were killed by decaptiation 24 or 48 hr alter exposure. 
sponse to organophosphorus compounds ad- 
ministered over a range of doses 24 and 48 hr Tissue Preparation 
prior to assay. 
Lymphocytes. Blood was collected immediately after 
killing in heparinized plastic syringes, diluted 1 .O/ 1.5 (v/ 
METHODS 
v) with room-temperature balanced salt solution (BSS; 
0.01% D-glucose, 5.0 mM CaCl2, 98.0 mM MgClz, 14.5 
Animals 
mM Tris, 126.0 mM NaCl, pH 7.6), and layered over Ficoll- 
Paque density medium (Pharmacia Fine Chemicals, Pis- 
cataway, N.J.) in siliconized glass culture tubes. The tubes 
Adult (over 1 year old) white leghorn hens were obtained were centrifuged at 400gay8 for 30 min at 20°C. Lympho- 
from Omega Chicks (Haslett, Mich.) at least 1 week prior cytes gathered at the density interface were collected with 
to experimentation. The birds were maintained (3 to 4 plastic transfer pipets and placed in clean siliconized tubes. 
per cage) in an air-conditioned room (21 to 23°C) on a Cells were washed twice by suspension in BSS and cen- 
12-hr light-dark cycle in 0.8 X 0.8 X 0.9-m stainless-steel trifugation at IOOOg,, for 10 min at 20°C. An aliquot of 
cages with wire bottoms. Except for the fasting procedure the final cell suspension was counted in a Model ZBI 
prior to dosing, animals were given Purina Layena mash Coulter counter (Coulter Electronics, Hialeah, Fla.), and 
(Ralston Purina, St. Louis, MO.) and tap water adlibitum. the final pellet was stored at -8O’C for no more than 24 
hr prior to NTE assay. Lymphocyte pellets were allowed 
Chemicals 
to thaw at room temperature, suspended in 2.00 ml of 50 
mM Tris-HCl/O.ZO mM EDTA buffer (pH 8.00 at 25”C), 
and sonicated for 10 set at a power output of 50 W with 
Diethyl 4nitrophenylphosphate, methyl 2,5-dichloro- a Branson cell disrupter (Branson Sonic Power, Danbury, 
4-bromophenyl phenylphosphonothionate (leptophos, Conn.) fitted with a microtip which was immersed halfway 
98% pure), and tri-2cresyl phosphate (tri-o-cresyl phos- into the suspension. The sonicate was then diluted with a 
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sufficient volume of buffer to make a final concentration 
equivalent to 2.0 X 10’ cells/ml. 
Brain. Brains were rapidly removed from the skull at 
the time of death, blotted, weighed, and stored at -80°C 
for no more than 24 hr prior to NTE assay. After being 
allowed to thaw at room temperature, a 10% (w/v) ho- 
mogenate of brain in ice-cold 50 mM Tris-HCl/O.ZO mM 
EDTA buffer (pH 8.00 at 25°C) was made with 10 strokes 
of a glass-tenon homogenizer (clearance approximately 
0.25 mm) fitted to a 2300 rev/min drill press. An aliquot 
of this homogenate was diluted with buffer to a tissue con- 
centration of 2.0 mg/ml. 
Biochemical Assays 
Neurotoxic esterase (NTE). NTE activity was assayed 
by calorimetric determination of the difference in phenol 
production by hydrolysis of PV between paired samples 
preincubated with paraoxon alone versus paraoxon plus 
mipafox. The procedure described by Johnson (1977) was 
modified and optimized for assay of both lymphocyte and 
brain NTE as follows: Tissue suspensions (equivalent to 
1.0 mg brain or 1.0 X IO’ lymphocytes) in 0.50 ml of 
buffer (50 mM Tris-HCI/O.ZO mM EDTA, pH 8.00 at 
25°C) were mixed at zero time with 0.50 ml of buffer 
containing either 200 pM paraoxon or 200 pM paraoxon 
plus 100 pM mipafox and preincubated for exactly 20 min 
in a circulating water bath at 37°C. PV (30 mg dissolved 
in 1 .O ml of dimethylformamide) was mixed with 30.0 ml 
of 0.03% (w/v) aqueous Triton X-100 to make a micellar 
suspension and 1 .OO ml of this substrate mixture was added 
to the preincubate at the end of the 20-min preincubation 
period. The reaction with substrate was allowed to proceed 
for exactly 30 min before stopping with 1 .OO ml of 1 .O% 
(w/v) sodium dodecyl sulfate in 500 mM Tris-HCl buffer 
(pH 9.00 at 25°C) containing 0.025% (w/v) 4-aminoan- 
tipyrine. Color was developed at room temperature by 
adding 0.50 ml of aqueous 0.40% (w/v) potassium ferri- 
cyanide and its absorbance was measured at 5 10 nm rel- 
ative to deionized-distilled water in a Sequoia-Turner 
Model 340 spectrophotometer (Mountain View, Calif.). 
The absorbance difference between paired tubes prein- 
cubated with paraoxon alone versus paraoxon plus mi- 
pafox has been operationally defined to be due to hydrolysis 
of PV by NTE (Johnson and Richardson, 1983) and that 
value was used for specific activity determination. The 
molar absorptivity at 5 10 nm for the color product was 
determined from phenol standards to be 13,900 M-’ cm-‘. 
Because of the differential nature of the assay, tissue and 
reagent blanks are automatically subtracted. However, a 
reagent blank was routinely included as a check on the 
free phenol content of the substrate. Specific enzyme ac- 
tivity was calculated as nmol substrate hydrolyzed/min 
X mg protein. Percentage enzyme inhibition was calcu- 
lated by dividing the specific enzyme activity in individual 
tissues from treated animals by the mean specific activity 
in controls, subtracting this ratio from 1.00, and multi- 
plying by 100. 
Acetylcholinesterase. Brain acetylcholinesterase (AChE) 
was assayed by a modification of the method of Ellman 
et al. ( 196 l), which has been previously described (Schwab 
and Murphy, 198 1). Specific activity and enzyme inhibi- 
tion were calculated as for NTE. 
Protein. Protein was assayed using the Bio-Rad protein 
assay kit (Bio-Rad Laboratories, Richmond, Calif.) based 
on Bradford’s dye-binding method (Bradford, 1976). Bo- 
vine serum albumin, fraction V (Sigma Chemical Co.), 
was used as a reference standard. 
Statistical Analysis 
To determine the statistical significance of the effect of 
paraoxon on brain AChE and brain lymphocyte NTE, 
unpaired t tests were performed on the mean values ob- 
tained from tissues from treated versus control animals. 
Linear regression analysis was used to examine the cor- 
relation of NTE inhibition between tissues in animals given 
TOCP, leptophos, or DBDCV 24 or 48 hr prior to killing. 
Brain inhibition (on the ordinate) was paired with lym- 
phocyte inhibition (abscissa) from the same animal and 
regression lines were fitted to the data for each compound 
at each of the two time points using the method of least 
squares. Inference on the correlation of inhibition between 
tisues was made by t test on the coefficient of determination 
(r’) of the regression lines. The null hypothesis in this test 
is that r2 is equal to zero, i.e., that no correlation exists 
(Goldstein, 1964). Additionally, paired t tests were per- 
formed on the values obtained for brain and lymphocyte 
NTE inhibition from each individual dosing group. Where 
mean values for data are presented, +SE is also given, 
with the number of observations (animals) indicated in 
parentheses; p < 0.05 was regarded as significant for t tests. 
RESULTS 
All animals survived exposure to the test 
compounds. Dosed animals appeared to be 
less active in their cages than controls follow- 
ing dosing, but the only unequivocal clinical 
difference detected between treated and con- 
trol animals occurred in paraoxon-dosed birds. 
Paraoxon, 0.75 mg/kg, inhibited brain 
AChE by 56 + 4% (n = 16, p < 0.001) and 
produced mild cholinergic signs (muscle fas- 
ciculations). This dose did not significantly 
inhibit either brain or lymphocyte NTE. Mean 
inhibition was 1 + 2% and 7 + 8% for brain 
and lymphocytes, respectively (relative to re- 
spective control activities of 5 1.2 + 0.85 nmol 
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and 9.92 + 0.68 nmol PV hydrolyzedlmin 
X mg protein; n = 7). 
TOCP, leptophos, and DBDCV inhibited 
brain and lymphocyte NTE in a dose-respon- 
sive manner. When measured in tissues from 
animals killed 24 hr after exposure, there was 
good agreement between brain and lympho- 
cyte NTE inhibition. Coefficients of determi- 
nation (r*) were 0.67 (n = 12, p < O.OOS), 0.53 
(I? = 11, p < 0.020), and 0.53 (n = 18, p 
< 0.001) for TOCP, leptophos, and DBDCV 
regressions, respectively. Observations on tis- 
sues taken 48 hr after exposure contrasted with 
the previous data. Coefficients of determina- 
tion were lower in all regressions of 48 hr data, 
and significantly different from zero only for 
DBDCV. The 48-hr r* values were 0.15 (n 
= 22, 0.05 < p < O.lO), 0.30 (n = 11, 0.05 
< p < O.lO), and 0.30 (n = 16, p < 0.05) for 
TOCP, leptophos, and DBDCV, respectively. 
Scattergrams and fitted regression lines of these 
data are presented in Figs. 1 to 3. 
Mean NTE inhibition in brain and lym- 
phocytes from the 10 dosing groups killed 24 
hr after exposure are presented in Figs. 4 to 6. 
NTE inhibition was similar for brain and 
lymphocytes in most groups. Statistically sig- 
nificant differences in brain versus lymphocyte 
inhibition were seen in only 2 of these groups 
(TOCP, 50 mg/kg; and leptophos, 25 mg/kg), 
and the direction of the differences were op- 
posite. There were 9 dosing groups killed 48 
hr after exposure (a 1 mg/kg DBDCV group 
was included at 24 hr but not at 48 hr). Mean 
inhibition data from these animals are pre- 
sented in Figs. 4 to 6. At 48 hr, the mean NTE 
inhibition value of lymphocytes was lower 
than that observed in brain in every case, with 
the difference being statistically significant in 
4 of the groups (TOCP, 50 and 100 mg/kg; 
leptophos, 75 mg/kg; and DBDCV, 3 mg/kg). 
DISCUSSION 
It would be useful in both clinical and ex- 
perimental situations to be able to easily mon- 
itor absorption of axonotoxic organophos- 
phorus compounds. Many of these com- 
pounds produce no acute signs, so that the 
24 hr 
i 
FIG. 1. Linear regression of percentage inhibition of 
brain NTE on percentage inhibition of lymphocyte NTE 
in hens treated po with 10 (O), 50 (m), and 100 (A) mg/ 
kg TOCP at 24 hr, or with 10 (0), 50 (Cl), and 100 (A) 
mg/kg/ TOCP at 48 hr prior to killing. The regression 
equation of the 24-hr line (n = 10) is y  = 0.94.x + 4.85; 
r* = 0.67, p < 0.005 (t test). The regression equation of 
the 48-hr line (n = 22) is y  = 0.34x + 48.95; r2 = 0.15, p 
z 0.05 (t test). 
first indication of toxic exposure would be the 
onset of peripheral neuropathy some weeks 
following insult. It would be preferable to have 
a system capable of indicating systemic ab- 
sorption in much shorter periods of time and 
sensitive enough to disclose situations which 
should be interrupted before sufficient expo- 
sure had occurred to cause overt toxic damage. 
In experimental animals, brain NTE inhibi- 
tion may be reliably measured within a few 
hours following exposure to axonotoxic or- 
ganophosphorus compounds at doses below 
the threshold for detection of clinically ap- 
parent neuropathy (Johnson and Richardson, 
1983). However, there are practical limitations 
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PIG. 2. Linear regression of percentage inhibition of 
brain NTE on percentage inhibition of lymphocyte NTE 
in hens treated po with 25 (a), 75 (m), and 150 (A) mg/ 
kg leptophos at 24 hr, or with 25 (0), 75 (Cl), and 150 (A) 
mgjkg leptophos at 48 hr prior to killing. The re- 
gression equation of the 24-hr line (n = 11) is y  = 1.78x 
- 44.15; r2 = 0.53, p < 0.02 (t test). The regression equation 
of the 48-hr line (n = 11) is y  = 0.53x + 36.75; r* = 0.30, 
p > 0.05 (t test). 
to a brain assay. Clearly, it is usually not pos- 
sible or desirable to obtain central nervous 
system tissue from patients. Likewise, in stud- 
ies with experimental animals, obtaining data 
on brain NTE inhibition often entails killing 
one group of animals while a pair-dosed group 
is used for further procedures. Our present and 
past (Richardson and Dudek, 1983) observa- 
tions suggest that assay for inhibition of lym- 
phocyte NTE up to 24 hr after exposure to an 
organophosphorus compound may be used in 
lieu of assay of brain tissue to indicate the ax- 
onopathic potential of an exposure. An ob- 
vious advantage of lymphocyte monitoring is 
that tissue for assay may be obtained relatively 
innocuously. 
While lymphocyte measurements have 
good potential as a monitor of acute exposures 
to axonotoxic organophosphorus compounds 
in both experimental and clinical situations, 
our results suggest that lymphocyte NTE as- 
says are limited in their applicability with re- 
spect to the period between exposure and 
measurement. At 48 hr after exposure, there 
is poor correlation between NTE inhibition in 
brain versus lymphocytes and it is not likely 
that much insight about the exposure or its 
consequences could be gained from lympho- 
cyte assay at this time point. The unsatisfac- 
tory correlation between brain and lympho- 
cytes 48 hr after an acute dose of an axonotoxic 
24 hr 
FIG. 3. Linear regression of percentage inhibition of 
brain NTE on percentage inhibition of lymphocyte NTE 
in hens treated po with 1.0 (O), 2.0 (O), 3.0 (w), and 4.0 
(A) m&g DBDCV at 24 hr, or with 2.0 (0), 3.0 (Cl), and 
4.0 (A) m&kg DBDCV at 48 hr prior to killing. The 
regression equation of the 24-hr line (n = 18) is y  = 0.89x 
+ 8.92; r2 = 0.53, p < 0.001 (t test). The regmssion equation 
of the 48-hr line (n = 16) is y  = 0.45~ + 37.42; rz = 0.30, 
p c 0.05 (t test). 
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FIG. 4. Mean percentage inhibition (+ SE) of brain (0) 
and lymphocyte (a) NTE in hens given 10, 50, or 100 
mg/kg TOCP po, either 24 or 48 hr prior to killing. At 24 
hr, there were no significant differences between brain and 
lymphocyte NTE inhibitions at 100 (n = 3) or 10 mg/kg 
(n = 4), but lymphocyte NTE inhibition was significantly 
less than brain NTE inhibition at 50 mg/kg (n = 3, p 
< 0.05; paired t test). At 48 hr, mean percentage inhibition 
of lymphocyte NTE was consistently lower than that for 
brain in all dosage groups; the differences were significant 
(paired t test) for 100 mg/kg (n = 8, p i 0.05) and 50 mg/ 
kg (n = 6, p < O.Ol), but not for 10 mg/kg (n = 8, p 
> 0.05). 
organophosphorus compound is reminiscent 
of the lack of correspondence between brain 
and lymphocyte inhibition reported by Lotti 
and Johnson ( 1980) following subchronic ex- 
posure of hens to mono-2-cresyl diphenyl 
phosphate. It would be profitable to study the 
biological events which undo correlation be- 
tween brain and lymphocyte NTE at 48 hr, in 
case they might in some way be circumvented. 
An alternative approach may be to use another 
blood component with NTE activity, such as 
platelets (Bleeker et al., 1983; Richardson and 
Dudek, 1983), but studies on the stability and 
dose dependency of inhibition of NTE in these 
blood elements are incomplete. 
Animals killed 48 hr after exposure to the 
test compounds also had consistently less NTE 
inhibition in lymphocytes relative to brain. We 
presume that the divergence of brain and lym- 
phocyte NTE inhibition is due to dissimilar 
kinetics of reappearance of enzyme activity. 
Return of activity of an inhibited enzyme may 




FIG. 5. Mean percentage inhibition (+ SE) of brain (0) 
and lymphocyte (kB) in hens given 25, 75, or 150 mg/kg 
leptophos po, either 24 or 48 hr prior to killing. At 24 hr, 
there were no significant differences between brain and 
lymphocyte NTE inhibitions at 150 (n = 4) or 75 mg/kg 
(n = 4), but lymphocyte NTE inhibition was significantly 
greater than brain NTE inhibition at 25 mg/kg (n = 4, p 
< 0.05; paired t test). At 48 hr, mean percentage inhibition 
of lyphocyte NTE was consistently lower than that for 
brain in all dosage groups; the difference was significant 
(paired t test) for 75 mg/kg (n = 4, p < O.OOS), but not for 
150 (n = 3) or 25 mg/kg (n = 4). 







FIG. 6. Mean percentage inhibition (SE) of brain (0) 
and lymphocyte (B3) NTE in hens given 1.0, 2.0, 3.0, or 
4.0 mg/kg DBDCV po at 24 hr prior to killing, or 2.0, 
3.0, or 4.0 mg/kg DBDCV po at 48 hr prior killing. At 24 
hr, there were no significant differences 0, > 0.05, paired 
t test) between brain and lymphocyte NTE inhibition for 
any dosage group (n = 3, 6, 6, and 3 for the 1.0, 2.0, 3.0, 
and 4.0 mg/kg groups, respectively). At 48 hr, mean per- 
centage inhibition of lymphocyte NTE was consistently 
lower than that for brain in all dosage groups; the difference 
was significant (paired t test) for 3.0 mg/kg (n = 7, p 
< 0.05). but not for 4.0 (n = 3) or 2.0 mg/kg (n = 6). 
zyme, de ~OVO enzyme (protein) synthesis, or 
turnover of cells containing the activity. Re- 
synthesis of enzyme is believed to be the 
mechanism of return of NTE activity in neural 
tissue, as reactivation by dephosphorylation 
has been shown to be slight and nervous sys- 
tem tissue is not comprised of cell populations 
with high rates of turnover (Johnson, 1982; 
Richardson, 1984). The relative contributions 
of different mechanisms for recovery of NTE 
activity in lymphocytes have not been studied. 
In contemplating such studies, one should 
consider more than the normal rates of protein 
or cell turnover in lymphocytes. Indeed, there 
are reports indicating that treatment with or- 
ganophosphorus compounds may alter the 
function or the constituents of the lymphocyte 
population (Watanabe and Sharma, 1977; Foil 
et al., 1981; Ehrich and Gross, 1983). 
Comparative studies of avian and mam- 
malian systems using both acute and chronic 
exposures may be useful in interpreting results 
of lymphocyte NTE measurements in hu- 
mans. Lotti er al., (1983) have conducted a 
field study of seven workers exposed daily for 
up to 34 days to S,S,S-tributylphosphorotri- 
thiolate (DEF) and tributylphosphorotrithioite 
(merphos), in which decreases in lymphocyte 
NTE of approximately 50% of preexposure 
values were reported between days 25 and 30 
of exposure, with no concomitant signs or 
symptoms of neurological abnormalities de- 
tected in any of the subjects at any time during 
the exposure or at 3 weeks after termination 
of exposure. This would indicate a positive re- 
sponse of human lymphocyte NTE following 
exposure to organophosphorus compounds 
with experimentally demonstrated axonotoxic 
potential (Davis et al., 1985). In view of the 
lack of detectable neurological abnormalities 
in the exposed humans, the NTE inhibition 
in each individual’s nervous system was pre- 
sumably below the threshold required for 
expression of clinical effects, although no 
neural tissue was available for determination 
of correlation. 
The fact that the NTE assay is quantitative 
makes it useful for ranking the relative potency 
of axonopathic organophosphorus compounds 
as well as discovering axonopathic potential 
at subclinical doses. However, the often- 
quoted “threshold” of approximately 70% in- 
hibition of whole-brain NTE following an 
acute exposure (Johnson and Richardson, 
1983) should not be taken as an absolute cor- 
relate of the dividing line between the subse- 
quent presence or absence of neuropathy. We 
found that 100 mg/kg TOCP produced brain 
NTE inhibitions of 69 and 75% at 24 and 48 
hr, respectively, whereas the ED50 for clini- 
cally apparent neuropathy has been reported 
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to be 200 to 250 mg/kg (Aldridge and Barnes, 
196 1; Watanabe and Sharma, 1976). Neurop- 
athy is not generally seen at lower doses be- 
cause the dose-response curve for inhibition 
of hen brain NTE 24 hr after a single oral dose 
of TOCP rises sharply to an ED50 of 40 mg/ 
kg and then becomes relatively flat, so that 
inhibition increases from 70 to 95% between 
100 and 1000 mg/kg; to ensure obvious clin- 
ical neuropathy, doses of 500 to 1000 mg/kg 
are commonly used (Dudek, 1979). Likewise, 
Lotti and Johnson ( 1980) found that 80 to 90% 
inhibition is required for unequivocal clinical 
neuropathy from single oral doses of mono- 
2-cresyl diphenylphosphate. 
Route of administration and chemical pu- 
rity may affect the amount of active inhibitor 
that reaches the target, so that the inclusion 
of NTE inhibition data is much more infor- 
mative than merely stating the dose required 
to produce neuropathy. Thus, we found that 
dosing po with 3.0 mg/kg DBDCV produced 
only 64% inhibition of brain NTE at 24 hr, 
but in independent work in our laboratory 
(Huggins, 1982) dosing SC with 2.8 mg/kg 
DBDCV was sufficient to nroduce >80% in- 
objective and quantifiable endpoints such 
as histopathological and electrophysiological 
changes would be helpful in determining 
whether subclinical damage is produced by 
lower levels of NTE inhibition than have 
heretofore been associated with the production 
of neuropathy. 
Future work on lymphocyte NTE should 
further explore the advantages and limitations 
of its use as a biomonitor of axonotoxic or- 
ganophosphorus compound exposure. More- 
over, the possibility that NTE may be involved 
in functional or pathological interrelationships 
between the nervous system and the immune 
system certainly deserves further study (Dudek 
and Richardson, 1982). Proteins expressed in 
greatest concentration in brain and lympho- 
cytes, such as NTE (Dudek and Richardson, 
1982; Williams, 1983) may be part of such 
relationships as has been demonstrated or 
postulated for other proteins with similar dis- 
tribution (Barclay and Hyden, 1978; Golub, 
1982; McKenzie et al., 1982). 
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